BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 368899)

  • 1. [Evaluation of the effects of terbutaline and orciprenaline by oral administration in patients with bronchial obstruction].
    Vargas FS; Pereira LC; Barbas Filho JV; Romeiro Neto MM
    AMB Rev Assoc Med Bras; 1978 Sep; 24(9):328-30. PubMed ID: 368899
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the effects of terbutaline and orciprenaline by subcutaneous administration in bronchial obstruction].
    Vargas FS; Pereira LC; Barbas Filho JV; Romeiro Neto MM
    AMB Rev Assoc Med Bras; 1978 Jan; 24(1):5-7. PubMed ID: 345368
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison between the effects of a new sympathomimetic beta receptor (Terbutaline) and orciprenaline].
    Roy JC; Binet G; Bussières C; Proulx PA
    Union Med Can; 1975 Jan; 104(1):93-8. PubMed ID: 1089333
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiorespiratory effects of oral terbutaline and an ephedrine-theophylline-phenobarbital combination: comparison in patients with chronic obstructive ventilatory disorders.
    Cohen BM
    Ann Allergy; 1978 Apr; 40(4):233-9. PubMed ID: 345887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ipratropine and terbutaline. A comparative study of 19 patients with chronic obstructive lung diseases].
    Petersen BN; Weeke E
    Ugeskr Laeger; 1979 Sep; 141(36):2439-42. PubMed ID: 160643
    [No Abstract]   [Full Text] [Related]  

  • 7. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
    Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
    Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled clinical trial of a new dosage form of metaproterenol.
    Beck GJ
    Ann Allergy; 1980 Jan; 44(1):19-22. PubMed ID: 6986110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of a new bronchiolytic preparation terbutaline in the treatment of patients with obstructive lung diseases].
    Adylova NA
    Ter Arkh; 1974; 46(5):122-5. PubMed ID: 4610870
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of terbutaline in exercise-induced asthma.
    Morse JL; Jones NL; Anderson GD
    Am Rev Respir Dis; 1976 Jan; 113(1):89-92. PubMed ID: 1108720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lung function studies with the bronchodilator terbutaline].
    Kaik G; Bonelli J; Hitzenberger G; Laggner A; Magometschnigg D
    Acta Med Austriaca; 1979; 6(2):1-39. PubMed ID: 517068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of obstructive airways disease in pediatric patients with new beta2 sympathomimetic bronchodilators.
    Marks MB
    Chest; 1978 Jun; 73(6 Suppl):1010-1. PubMed ID: 354879
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of the aerosolized bronchodilators, isoproterenol, metaproterenol and terbutaline in asthma.
    Roth MJ; Wilson AF; Novey HS
    Ann Allergy; 1977 Jan; 38(1):16-21. PubMed ID: 319711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective and subjective tremor responses to oral beta 2 agents on first exposure. A comparison of metaproterenol and terbutaline.
    Jenne JW; Ridley DJ; Marcucci RA; Druz WS; Rook JC
    Am Rev Respir Dis; 1982 Oct; 126(4):607-10. PubMed ID: 6751176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of onset of bronchodilating effect by interruption of the air flow method.
    Lulling J; Delwiche JP; Prignot J
    Eur J Respir Dis; 1980 Apr; 61(2):108-12. PubMed ID: 7002572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peroral terbutaline in the treatment of patients with severe irreversible obstructive pulmonary disease].
    Maltbaek N; Christensen HR; Garsdal P; Bro H; Rasmussen FV
    Ugeskr Laeger; 1990 Mar; 152(11):729-32. PubMed ID: 2181755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of terbutaline and glyceryl guaiacolate in chronic obstructive lung disease.
    Kokkola K; Vaara J
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):397-404. PubMed ID: 817870
    [No Abstract]   [Full Text] [Related]  

  • 18. Aerosolized terbutaline sulfate in the treatment of bronchospasm.
    Scoggin CH
    Clin Ther; 1984; 6(5):603-12. PubMed ID: 6434183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inhaled N-acetylcysteine in combination with terbutaline.
    Stiksa G; Nemcek K; Melin S
    Eur J Respir Dis; 1984 May; 65(4):278-82. PubMed ID: 6723838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies on the oral therapy of obstructive respiratory tract diseases with clenbuterol, fenoterol and depot-orciprenaline (double-blind study)].
    Flohr E; Bischoff KO
    Verh Dtsch Ges Inn Med; 1978; (84):417-20. PubMed ID: 369198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.